Anti-rabies vaccine
Anti-rabies vaccine is the immunization which prevents infection with the virus that causes rabies. Anti-rabies vaccine is given for Category II (minor scratches without bleeding from contact, or licks on broken skin) and Category III (one or more bites, scratches, licks on broken skin, or other contact that breaks the skin; or exposure to bats) exposures. Antirabies vaccines are of 2 types-Neural and Non-neural vaccines. Though neural tissue vaccines are not directed by WHO to use by its member nations, still these vaccines are used in many developing nations because of their low cost. Non-neural vaccines were developed for reducing the neuroparalytic complications associated with the nervous tissue vaccines.
Primary Characteristics
It is of Semi Synthetic origin.
Non-proprietary name: Anti-rabies vaccine.

Pharmacokinetics
None recorded.
Advertisement
Indications
Anti-rabies vaccine is primarily indicated in conditions like Neuroparalytic complications associated with the nervous tissue vaccines., Post-exposure prophylaxis, Pre-exposure prophylaxis.
Contraindications
None recorded.
Dosage
None recorded.
Drug Interactions
None recorded.
Side Effects
Anti-rabies vaccine is known to cause more or less tolerable side effects which are usually transient. These include Dizziness, Gastrointestinal disturbances, Headache, Hypersensitivity reactions, Itching, Local pain, Malaise.
Warnings / Precautions
Available Brands
None recorded.
Drug Classification
- 1.19.3.2 — Vaccines for specific groups of individuals